FDA Inspection 1309368 — Emergent Biodefense Operations Lansing LLC

Emergent Biodefense Operations Lansing LLC — FEI 3004051669

The FDA completed an inspection of Emergent Biodefense Operations Lansing LLC on February 10, 2026 in Canton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 10, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Canton, MA (United States)